Innate Pharma S.A.

IPH.PA · PAR
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Assets
Cash & Equivalents€53,704€66,396€69,990€70,605
Short-Term Investments€6,323€14,374€21,809€21,851
Receivables€363€4,972€393€46,489
Inventory€0€0€0€0
Other Curr. Assets€2,437-€3,329€16,393€0
Total Curr. Assets€64,978€85,742€111,594€148,012
Property Plant & Equip (Net)€4,955€5,133€5,748€6,322
Goodwill€0€0€0€0
Intangibles€0€0€119€416
Long-Term Investments€10,390€19,609€10,350€9,796
Tax Assets€0€0€9,123€9,006
Other NC Assets€12,614€575€14,563€10,641
Total NC Assets€27,959€25,317€39,903€36,181
Other Assets€0€0€0€0
Total Assets€92,937€111,059€151,497€184,193
Liabilities
Payables€4,551€16,007€8,751€8,561
Short-Term Debt€8,470€8,709€8,506€8,451
Tax Payable€0€0€0€7,021
Deferred Revenue€0€616€2,799€5,865
Other Curr. Liab.€15,941€7,379€17,745€16,275
Total Curr. Liab.€29,426€32,982€38,224€39,637
LT Debt€17,944€22,286€26,410€30,607
Deferred Rev, NC€2,628€2,825€4,116€4,618
Deferred Tax Liab, NC€0€0€9,123€9,006
Other NC Liab.€37,644€44,132€44,665€39,069
Total NC Liab.€58,367€69,243€84,477€92,655
Other Liabilities€0€0€0€0
Cap. Leases€615€375€587€350
Total Liabilities€87,793€102,225€122,701€132,292
Equity
Pref Stock€0€0€0€0
Common Stock€4,610€4,192€4,049€4,044
Retained Earnings-€407,708-€386,364-€361,657-€336,893
AOCI€1,194€27€355€495
Other Equity€0€0€0€0
Total Equity€5,144€8,834€28,796€51,901
Supplemental Information
Minority Interest€0€0€0€0
Total Liab. & Tot. Equity€92,937€111,059€151,497€184,193
Net Debt-€27,290-€35,401-€35,074-€31,547